AIM
MYOV

Aigen Investment Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Aigen Investment Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,379
Closed -$312K – 835
2022
Q3 		$312K Buy
+17,379
New +$277K 0.04% 393

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Aigen Investment Management's MYOV Position: Q4 2022 in Review

Aigen Investment Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 17,379 shares — an estimated $312K sold.

Aigen Investment Management first reported a position in MYOV in Q3 2022 and held it in 1 quarter. The position peaked at $312K in Q3 2022. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Aigen Investment Management reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Aigen Investment Management sold 17,379 Myovant Sciences Ltd. shares in Q4 2022, an estimated $312K.
  • Aigen Investment Management first reported a position in Myovant Sciences Ltd. in Q3 2022 and held it in 1 quarter.
  • Aigen Investment Management's Myovant Sciences Ltd. position peaked at $312K in Q3 2022.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Aigen Investment Management's 13F filing for Q4 2022, filed 10 Feb 2023.